Testing Resomelagon for dengue fever
Part of Infections clinical trials.
This trial tests whether a new medicine called Resomelagon can safely treat dengue fever. It looks at how well the medicine works and if it helps you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had dengue symptoms like fever, headache, or body aches for less than 84 hours (3.5 days).
- You have tested positive for dengue.
- You do not have other serious health conditions or abnormal blood test results.
- You are not pregnant or planning to become pregnant.
- You are not currently in another drug trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether zanamivir given through a vein can improve outcomes in people with dengue infection who have warning signs. It may help by reducing the body problems dengue can cause in blood vessels and fluid balance.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This trial tests whether a medicine called emetine can help adults hospitalized with dengue. If you have a confirmed dengue infection and symptoms like fever, headache, or body aches, this study may be for you.
This trial tests new treatments for people hospitalized with moderate to severe dengue, a mosquito-borne illness. It aims to find better ways to reduce symptoms and prevent serious complications.
Hear when a new Dengue Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.